3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 4
1
Status
Recruiting
2
Terminated
1
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Interventional
3
Sponsor
Cancer Type
Myeloid
3
Conditions
Polycythemia Vera
3
Treatment-Refractory Solid Tumors
2
Meningioma
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Interventions
ruxolitinib
6
Hydroxyurea
3
fludarabine phosphate
2
bomedemstat
2
Whole-Body Irradiation
2
Tacrolimus
2
Specimen Handling
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Injections
2
Cyclophosphamide
2
Busulfan
2
Biopsy
2
veliparib
1
umbralisib
1
piperine
1
iadademstat
1
givinostat hydrochloride
1
givinostat
1
fludarabine
1
fedratinib
1
demethoxycurcumin
1
decitabine and cedazuridine drug combination
1
Transplantation
1
Topotecan
1
Stem Cell Transplantation
1
Sirolimus
1
Resistance Training
1
Radiotherapy
1
Panobinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Polycythemia Vera
×
Hydroxyurea
×
90 days
×
Clear all
NCT05853458
2026-04-30
HU-F-AIM
Novartis
Phase 4
Terminated
76 enrolled
NCT04116502
2026-04-28
MITHRIDATE
University of Birmingham
Phase 3
Recruiting
586 enrolled
NCT06093672
2026-03-25
GIV-IN-PV
Italfarmaco
Phase 3
Recruiting
220 enrolled